BIO Board of Directors
In accordance with its Bylaws and Articles of Incorporation, the Biotechnology Innovation Organization (BIO) is governed by its Board of Directors. The Full BIO Board of Directors is comprised of all the directors sitting on the Section Governing Boards, as described below.
In addition, there is a Board Executive Committee that consists of the seven Elected Officers of the Organization, the immediate Past Chair of the Organization, the Vice Chairs of each Section's Governing Board, and At-Large Directors selected from the Full Board.
There are four Section Governing Boards organized by industrial sector and policy interest. They are: (1) the Emerging Companies Section (ECS) Governing Board, (2) the Food & Agriculture (F&A) Section Governing Board, (3) the Health Section Governing Board, and (4) the Industrial & Environmental (I&E) Section Governing Board. BIO’s four Section Governing Boards are comprised of thought leaders who bring their expertise to bear on major issues affecting their specific area of the biotechnology industry.
From time to time, each Section Governing Board may consider candidates to fill vacancies in accordance with BIO’s Bylaws and their own processes and criteria. In general, BIO Board candidates should be the CEO or Chairman of the Board of a research and development (R&D) focused biotechnology company, but certain Governing Boards have alternative criteria, especially for larger companies. To be considered for a BIO Board seat, a candidate typically has this type of affiliation with a BIO member company. If your organization is not a BIO member, click here to learn more about membership.
BIO is committed to fostering workforce development, diversity, and inclusion (WDDI) at BIO and across the biotechnology industry. To that end, candidates should affirmatively support BIO’s WDDI Principles, and pledge to do her or his part to foster diversity and inclusion among employees, customers, and patients. BIO’s WDDI Principles can be found at: https://www.bio.org/diversity
If you are interested in nominating yourself or another person to be a candidate and potentially fill a vacancy on the BIO Board, please inquire here to learn more about the BIO Board nomination process:
Inquire about BIO Board Nominations
If you have any questions about the BIO Board of Directors, please contact Peter McHugh at pmchugh@bio.org.
For reference, a diagram of the Board and Committee structure is presented below.
Board and Committee structure
Executive Committee
Executive Committee
Chairman & CEO, Ovid Therapeutics Inc.
Chief Executive Officer, Alnylam Pharmaceuticals, Inc.
President & Chief Executive Officer, Cerevast Therapeutics, Inc.
Executive Vice President and Chief Patient Officer, Strategic Communications, Global Public Policy, Merck
President & CEO, Nkarta Therapeutics, Inc.
Chief Executive Officer, Global Blood Therapeutics
Chairman & CEO, Amicus Therapeutics, Inc.
Sr. Vice President, Agricultural Global Government Relations, Regulatory Policy, Bayer CropScience, Inc.
Chief Executive Officer, AquaBounty Technologies, Inc.
General Counsel, Secretary & President, DSM North America
Vice President, Bioindustrials NA, Cargill, Inc
Executive Vice President and Chief Commercial Office, Vertex Pharmaceuticals Incorporated
Founder, President & CEO, Acorda Therapeutics, Inc.
President & CEO, MaxCyte, Inc
Chief Executive Officer, Genentech, A Member of the Roche Group
Founder & CEO, GlycoMimetics, Inc.
Chairman & CEO, Alkermes, Inc.
Chief Executive Officer, Kite, a Gilead Company
Executive Vice President, Genzyme Corporation, A Sanofi Company
President & CEO, Halozyme Therapeutics, Inc.
Section Governing Boards
Emerging Companies Section Governing Board
Chief Executive Officer, Global Blood Therapeutics
Chairman & Chief Executive Officer, Veracyte, Inc.
President & CEO, Principia Biopharma
Partner, Cooley LLP
Chairman, CEO & President, Ashvattha Therapeutics, Inc.
Founder, President & CEO, Acorda Therapeutics, Inc.
Chairman & CEO, Amicus Therapeutics, Inc.
President & CEO, Director, Xencor, Inc
President & CEO, MaxCyte, Inc
Partner - Pharmaceuticals National Audit Leader, KPMG LLP
President & CEO, MeiraGTx
Co-Founder & CEO/President, Apellis Pharmaceuticals, Inc
Chief Executive Officer, Neurocrine Biosciences, Inc
Chief Executive Officer, GW Pharmaceuticals Plc
President & CEO, Nkarta Therapeutics, Inc.
President & CEO, Hydra Biosciences, Inc
Partner, Deerfield Management Company LP
Chief Executive Officer, Centrexion Therapeutics
Founder & CEO, GlycoMimetics, Inc.
President & CEO, MacroGenics, Inc
President & CEO, bluebird bio
Chairman & CEO, Ovid Therapeutics Inc.
President & CEO, Sangamo Therapeutics, Inc.
Chief Executive Officer, Alnylam Pharmaceuticals, Inc.
Co-Founder & CEO, Spark Therapeutics
Founder, Chairman & CEO, Intra-Cellular Therapies, Inc.
President & CEO, Cognition Therapeutics
Managing Director, Alta Partners
President & CEO, CODA Biotherapeutics
Managing Partner, Polaris Ventures
Chief Executive Officer, Sutro Biopharma, Inc.
President & CEO, Millendo Therapeutics Inc.
Chair & Chief Executive Officer, Infinity Pharmaceuticals, Inc.
President, CEO & Director, Intercept Pharmaceuticals, Inc.
Chief Executive Officer, Ardelyx Inc.
Executive Chairman, Marizyme Inc.
Chief Executive Officer & Director, VIR Biotechnology, Inc.
Chief Executive Officer & President, Syros Pharmaceuticals
Chief Executive Officer, ReNetX Bio
Founder, Chairman & CEO, Athersys, Inc.
Chairman, President & CEO, Horizon Therapeutics plc
President & CEO, Applied Genetic Technologies Corporation (AGTC)
Founder, CEO & Chairman of Board of Directors, Dermira, Inc.
Chairman, CymaBay Therapeutics
President & Chief Executive Officer, Cerevast Therapeutics, Inc.
Food & Ag Section Governing Board
Sr. Vice President, Agricultural Global Government Relations, Regulatory Policy, Bayer CropScience, Inc.
Vice President, Global Product Development, Elanco
President & CEO, Recombinetics, Inc
President & CEO, SAB Biotherapeutics
CEO & Co-Founder, Pivot Bio, Inc.
Senior Vice President, Seeds & Traits, BASF Corporation
Chief Executive Officer, AquaBounty Technologies, Inc.
Health Section Governing Board
Chairman & CEO, Ovid Therapeutics Inc.
President & CEO, Nkarta Therapeutics, Inc.
Chief Executive Officer, Alnylam Pharmaceuticals, Inc.
President & CEO, Halozyme Therapeutics, Inc.
Corporate Vice President, Market Access and Public Affairs, Novo Nordisk
Chairman & Chief Executive Officer, Veracyte, Inc.
Executive Vice President and Chief Commercial Office, Vertex Pharmaceuticals Incorporated
President & CEO, Principia Biopharma
Chairman & CEO, BioMarin Pharmaceutical, Inc.
General Manager, Amgen Inc.
Chairman, CEO & President, Ashvattha Therapeutics, Inc.
Founder, President & CEO, Acorda Therapeutics, Inc.
President, Inflammation and Immunology, Celgene Corporation
President & CEO, MaxCyte, Inc
President & CEO, ImmunoGen, Inc.
Executive Vice President & General Manager US, Incyte Corporation
President & CEO, MeiraGTx
Co-Founder & CEO/President, Apellis Pharmaceuticals, Inc
Executive Vice President and Chief Patient Officer, Strategic Communications, Global Public Policy, Merck
EVP, Global Product Strategy & Commercialization, Biogen
President of Pharmaceuticals, Americas Region, Bayer Corporation
Chief Executive Officer, Genentech, A Member of the Roche Group
President, Corporate Affairs and Global Patient Relations, Grifols
Founder & CEO, GlycoMimetics, Inc.
President & CEO, MacroGenics, Inc
Executive Vice President, General Counsel and Secretary, Regeneron Pharmaceuticals, Inc.
SVP, R&D Pipeline, GlaxoSmithKline
President & CEO, bluebird bio
Chief Counsel, Specialty BUs & R&D; Head, Patient Advocacy, Oncology BU, Takeda Pharmaceutical Company Limited
Chief Executive Officer, Global Blood Therapeutics
President & CEO, Sangamo Therapeutics, Inc.
Global Head of Biotherapeutics Discovery Research and Discovery Research Site Head, Boehringer Ingelheim
Executive Vice President and Head, US Novartis Oncology, Novartis
Co-Founder & CEO, Spark Therapeutics
Founder, Chairman & CEO, Intra-Cellular Therapies, Inc.
President & CEO, Cognition Therapeutics
President & CEO, Exelixis, Inc.
President & CEO, CODA Biotherapeutics
Chief Executive Officer, Sutro Biopharma, Inc.
EVP & Chief R&D Officer, Allergan
President & CEO, Millendo Therapeutics Inc.
CEO & Co-Founder, BeiGene, Ltd.
EVP & CEO of Ipsen NA, Ipsen Biopharmaceuticals, Inc.
Chair & Chief Executive Officer, Infinity Pharmaceuticals, Inc.
Chairman & CEO, Alkermes, Inc.
President & COO, Eisai, Inc
President, CEO & Director, Intercept Pharmaceuticals, Inc.
Chief Executive Officer, Ardelyx Inc.
President & CEO, Nektar Therapeutics, Inc.
SVP, Worldwide Value, Access, Policy & Health Economics & Outcomes Research, Bristol-Myers Squibb Company
Executive Vice President, Genzyme Corporation, A Sanofi Company
Chief Executive Officer & President, Syros Pharmaceuticals
President, U.S. Immunology and Patient Services, AbbVie Inc.
Worldwide Chairman of Pharmaceuticals, Johnson & Johnson
Chief Executive Officer, The Medicines Company
President & CEO, Mallinckrodt Pharmaceuticals
Founder, Chairman & CEO, Athersys, Inc.
Chief Operating Officer, UCB SA
Chairman, President & CEO, Horizon Therapeutics plc
President & CEO, Applied Genetic Technologies Corporation (AGTC)
Senior Vice President and President of Lilly Oncology, Eli Lilly and Company
Founder, CEO & Chairman of Board of Directors, Dermira, Inc.
Chief Executive Officer, Theravance Biopharma US, Inc.
Chief Business Officer, Pfizer Inc.
Chief Medical Officer, Astellas Pharma US, Inc.
Industrial & Environmental Section Governing Board
General Counsel, Secretary & President, DSM North America
Vice President, Bioindustrials NA, Cargill, Inc
Vice President, Corporate Affairs, Poet, LLC
Chief Executive Officer, Gevo, Inc
Chief Executive Officer, LanzaTech
President, Virent, Inc
Chief Executive Officer, Amyris, Inc.
President & CEO, Vestaron Corporation
Chief Executive Officer & Co-Founder, Genomatica, Inc
Director, Regulatory Affairs, BASF Enzymes LLC
Vice President, Legal Affairs, ICM, Inc
President & Chief Executive Officer, Edeniq Inc.
Chief Executive Officer, Evolva SA
Senior Vice President, Energy & Fine Chemicals Platforms, Intrexon Corporation
Founder, Managing Partner, Spruce Capital Partners